These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30053019)
21. In vivo development of tigecycline resistance in Klebsiella pneumoniae owing to deletion of the ramR ribosomal binding site. Ye M; Ding B; Qian H; Xu Q; Jiang J; Huang J; Ou H; Hu F; Wang M Int J Antimicrob Agents; 2017 Oct; 50(4):523-528. PubMed ID: 28668690 [TBL] [Abstract][Full Text] [Related]
22. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea. Kim SY; Shin J; Shin SY; Ko KS Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521 [TBL] [Abstract][Full Text] [Related]
23. Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics. Foudraine DE; Strepis N; Stingl C; Ten Kate MT; Verbon A; Klaassen CHW; Goessens WHF; Luider TM; Dekker LJM Sci Rep; 2021 Jun; 11(1):12472. PubMed ID: 34127720 [TBL] [Abstract][Full Text] [Related]
24. Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity. Nelson K; Hemarajata P; Sun D; Rubio-Aparicio D; Tsivkovski R; Yang S; Sebra R; Kasarskis A; Nguyen H; Hanson BM; Leopold S; Weinstock G; Lomovskaya O; Humphries RM Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739787 [TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. Doumith M; Ellington MJ; Livermore DM; Woodford N J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898 [TBL] [Abstract][Full Text] [Related]
26. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201 [TBL] [Abstract][Full Text] [Related]
27. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. Carvalhaes CG; Picão RC; Nicoletti AG; Xavier DE; Gales AC J Antimicrob Chemother; 2010 Feb; 65(2):249-51. PubMed ID: 19996141 [TBL] [Abstract][Full Text] [Related]
28. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR. Wang X; Chen H; Zhang Y; Wang Q; Zhao C; Li H; He W; Zhang F; Wang Z; Li S; Wang H Int J Antimicrob Agents; 2015 Jun; 45(6):635-40. PubMed ID: 25681067 [TBL] [Abstract][Full Text] [Related]
29. Changing Landscape of Antimicrobial Resistance in Neonatal Sepsis: An in silico Analyses of Multidrug Resistance in Klebsiella pneumoniae. Vijayakumar S; Kumar H; Basu S; Chandy S; Anbarasu A; Manoharan A; Ramaiah S Pediatr Infect Dis J; 2024 Aug; 43(8):777-784. PubMed ID: 38621154 [TBL] [Abstract][Full Text] [Related]
30. [Carbapenem resistance in Klebsiella pneumoniae clinical isolates from urinary tract infections]. Mereuţă AI; Enache EM; Dumitraşcu A; Vremeră T; Coman G Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):531-5. PubMed ID: 21870752 [TBL] [Abstract][Full Text] [Related]
31. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Hentschke M; Wolters M; Sobottka I; Rohde H; Aepfelbacher M Antimicrob Agents Chemother; 2010 Jun; 54(6):2720-3. PubMed ID: 20350947 [TBL] [Abstract][Full Text] [Related]
32. Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258. Iovleva A; Mettus RT; McElheny CL; Mustapha MM; Van Tyne D; Shields RK; Pasculle AW; Cooper VS; Doi Y J Antimicrob Chemother; 2019 Aug; 74(8):2203-2208. PubMed ID: 31127290 [TBL] [Abstract][Full Text] [Related]
33. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency. Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170 [TBL] [Abstract][Full Text] [Related]
34. Clonal Dissemination of OXA-232 Carbapenemase-Producing Klebsiella pneumoniae in Neonates. Yin D; Dong D; Li K; Zhang L; Liang J; Yang Y; Wu N; Bao Y; Wang C; Hu F Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533245 [TBL] [Abstract][Full Text] [Related]
35. High Osmotic Stress Increases OmpK36 Expression through the Regulation of KbvR to Decrease the Antimicrobial Resistance of Klebsiella pneumoniae. Wang M; Tian Y; Xu L; Zhang F; Lu H; Li M; Li B Microbiol Spectr; 2022 Jun; 10(3):e0050722. PubMed ID: 35658577 [TBL] [Abstract][Full Text] [Related]
36. In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae. Bialek-Davenet S; Marcon E; Leflon-Guibout V; Lavigne JP; Bert F; Moreau R; Nicolas-Chanoine MH Antimicrob Agents Chemother; 2011 Jun; 55(6):2795-802. PubMed ID: 21464248 [TBL] [Abstract][Full Text] [Related]
37. Outer membrane protein alterations and blaTEM-1 variants: their role in beta-lactam resistance in Klebsiella pneumoniae. Nelson EC; Segal H; Elisha BG J Antimicrob Chemother; 2003 Dec; 52(6):899-903. PubMed ID: 14613957 [TBL] [Abstract][Full Text] [Related]
38. In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification. Bialek-Davenet S; Mayer N; Vergalli J; Duprilot M; Brisse S; Pagès JM; Nicolas-Chanoine MH Sci Rep; 2017 Jul; 7(1):6722. PubMed ID: 28751669 [TBL] [Abstract][Full Text] [Related]
39. Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae. Jacoby GA; Mills DM; Chow N Antimicrob Agents Chemother; 2004 Aug; 48(8):3203-6. PubMed ID: 15273152 [TBL] [Abstract][Full Text] [Related]
40. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Veleba M; Higgins PG; Gonzalez G; Seifert H; Schneiders T Antimicrob Agents Chemother; 2012 Aug; 56(8):4450-8. PubMed ID: 22644028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]